AP NEWS

Global Sickle Cell Anemia Market and Competitive Landscape Report 2018: Definitions, Symptoms, Etiology, Diagnosis & Treatment Options - ResearchAndMarkets.com

October 5, 2018

DUBLIN--(BUSINESS WIRE)--Oct 5, 2018--The “Global Sickle Cell Anemia Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

Global Sickle Cell Anemia Market and Competitive Landscape 2018, provides comprehensive insights into Sickle Cell Anemia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Sickle Cell Anemia market size and drug sales. This research also provides insights into Sickle Cell Anemia epidemiology and late stage pipeline.

The research is classified into following sections - Sickle Cell Anemia overview with definitions, symptoms, etiology, diagnosis, treatment options; Sickle Cell Anemia pipeline insights covering late stage clinical trials pipeline; Sickle Cell Anemia prevalence trends by countries; Sickle Cell Anemia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan.

Research Scope:

Sickle Cell Anemia pipeline: Find out the drugs in clinical trials for Sickle Cell Anemia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Sickle Cell Anemia epidemiology: Find out the prevalence of Sickle Cell Anemia by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023 Sickle Cell Anemia products: Identify key products marketed and prescribed for Sickle Cell Anemia by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan Sickle Cell Anemia market size: Find out the market size for Sickle Cell Anemia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014 Sickle Cell Anemia drug sales: Find out the sales of Sickle Cell Anemia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global Sickle Cell Anemia drugs sales forecast: Sales forecast for Sickle Cell Anemia drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan Sickle Cell Anemia market share analysis: Find out the market shares of Sickle Cell Anemia drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

For more information about this report visit https://www.researchandmarkets.com/research/djkzzd/global_sickle?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181005005248/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Hematological Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH HOSPITALS PHARMACEUTICAL OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/05/2018 08:36 AM/DISC: 10/05/2018 08:36 AM

http://www.businesswire.com/news/home/20181005005248/en

AP RADIO
Update hourly